Search
Sonoma Pharmaceuticals Inc
SNOAAdd to Watchlist
1.100USD
-0.030-2.65%
Close 07-31 16:00（ET）Quotes delayed by 15 min
1.98MMarket Cap
LossP/E TTM
Earnings Forecast
Currency: USD Updated: 2026-07-31No earnings forecast score is currently available for Sonoma Pharmaceuticals Inc. The Pharmaceuticals industry's average is 7.87. The average price target is 14.80, with a high of 14.80 and a low of 14.80.
Analyst Rating
Based on
0
analysts
--
Current Rating
14.800
Target Price
+1198.25%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
160
Total
6
Median
9
Average
Company name
Ratings
Analysts
Sonoma Pharmaceuticals Inc
SNOA
0
Amgen Inc
AMGN
38
Biogen Inc
BIIB
38
Eli Lilly and Co
LLY
34
AbbVie Inc
ABBV
33
Pfizer Inc
PFE
32
1
2
3
...
32
Support & Resistance
Relevant data have not been disclosed by the company yet.
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FAQs
What is Sonoma Pharmaceuticals Inc's expected revenue for the next quarter?
Sonoma Pharmaceuticals Inc's expected revenue is 4.99M.
What is Sonoma Pharmaceuticals Inc's price target?
Analysts forecast that Sonoma Pharmaceuticals Inc's price target is USD 14.80, with the highest forecast at USD 14.80 and the lowest forecast at USD 14.80.
How have Sonoma Pharmaceuticals IncSNOA's recent earnings per share performed?
The market expectation was USD -0.33, while Sonoma Pharmaceuticals IncSNOA's earnings per share (EPS) for the previous quarter was USD -0.48. EPS for the next quarter is expected at USD -0.30.